An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan

E Tibirica, J Feldman, C Mermet, F Gonon and P Bousquet

Laboratoire de Pharmacologie Cardiovasculaire et Renale, CNRS URA 589, Faculte de Medecine, Universite Louis Pasteur, Strasbourg, France.

Our previous in vivo electrochemical studies in the normotensive rat have shown that there was a positive correlation between the hypotensive effect of low doses of clonidine (8-40 nmol/kg i.v.) and the inhibition of the metabolic activity of catecholaminergic neurons within the nucleus reticularis region in the brain stem. Higher doses of the drug (200 nmol/kg i.v.) were required to decrease the metabolic activity in the locus ceruleus, which is involved in the sedative effect of clonidine. To investigate further the pharmacological mechanism involved in the hypotensive effect of imidazolines, low doses of antagonists were injected centrally in the cisterna magna (5 nmol/kg intracisternal): idazoxan, an imidazoline that labels nonadrenergic imidazoline-preferring sites and yohimbine, which is a classical alpha- 2 adrenergic antagonist. Our results show that idazoxan very potently antagonizes both the hypotensive effect of clonidine and neuronal inhibition on the nucleus reticularis lateralis region but not in the locus ceruleus. The opposite effect is observed with yohimbine, i.e., neither the hypotensive effect nor the neuronal inhibition produced by clonidine on the nucleus reticularis lateralis region were affected but it prevented the inhibitory effect of clonidine on locus ceruleus neuronal metabolic activity. In conclusion, we confirm the hypothesis that the hypotensive action of imidazoline is due to an interaction of these substances with imidazoline-preferring receptors in the ventrolateral medulla oblongata whereas its sedative effect is related to an action on alpha-2 adrenoceptors.

Volume 256, Issue 2, pp. 606-613, 02/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K. Kagawa, Y. Hayashi, I. Itoh, M. Iwasaki, K. Takada, T. Kamibayashi, A. Yamatodani, and T. Mashimo Identification of the Central Imidazoline Receptor Subtype Involved in Modulation of Halothane-Epinephrine Arrhythmias in Rats Anesth. Analg., December 1, 2005; 101(6): 1689 - 1694. [Abstract] [Full Text] [PDF]

				M. M. El-Mas and A. A. Abdel-Rahman Effects of Chronic Ethanol Feeding on Clonidine-Evoked Reductions in Blood Pressure, Heart Rate, and Their Variability: Time-Domain Analyses J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 271 - 278. [Abstract] [Full Text] [PDF]

				M. Khalid, Y. Giudicelli, and J.-P. Dausse An Up-Regulation of Renal alpha 2A-Adrenoceptors Is Associated with Resistance to Salt-Induced Hypertension in Sabra Rats J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 928 - 933. [Abstract] [Full Text] [PDF]

				M. Yamazato, A. Sakima, J. Nakazato, S. Sesoko, H. Muratani, and K. Fukiyama Hypotensive and sedative effects of clonidine injected into the rostral ventrolateral medulla of conscious rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2001; 281(6): R1868 - R1876. [Abstract] [Full Text] [PDF]

				C. F. Plato and J. L. Garvin alpha 2-Adrenergic-mediated tubular NO production inhibits thick ascending limb chloride absorption Am J Physiol Renal Physiol, October 1, 2001; 281(4): F679 - F686. [Abstract] [Full Text] [PDF]

				D. O. Arnar, D. Xing, H.-C. Lee, and J. B. Martins Prevention of ischemic ventricular tachycardia of Purkinje origin: role for {alpha}2-adrenoceptors in Purkinje? Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1182 - H1190. [Abstract] [Full Text] [PDF]

				R.J. Moen, K. P. LaVoi, M. Zhang, and M. J. Blake Clonidine-Induced Heat-Shock Protein Expression in Rat Aorta Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(2): 171 - 184. [Abstract] [PDF]

				L. Liu and I. M. Coupar Involvement of Alpha-2 Adrenoceptors in the Effects of Moxonidine on Intestinal Motility and Fluid Transport J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1367 - 1374. [Abstract] [Full Text]

				D. J. Reis and J. E. Piletz The imidazoline receptor in control of blood pressure by clonidine and allied drugs Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1569 - R1571. [Abstract] [Full Text] [PDF]

				P. Ernsberger and M. A. Haxhiu The I1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1572 - R1579. [Abstract] [Full Text] [PDF]

				P. G. Guyenet Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites? Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1580 - R1584. [Abstract] [Full Text] [PDF]

				H. D. Intengan and D. D. Smyth Alpha-2a/d Adrenoceptor Subtype Stimulation by Guanfacine Increases Osmolar Clearance J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 48 - 53. [Abstract] [Full Text]

				J. A. Garcia-Sevilla, P. V. Escriba, M. Sastre, C. Walzer, X. Busquets, G. Jaquet, D. J. Reis, and J. Guimon Immunodetection and Quantitation of Imidazoline Receptor Proteins in Platelets of Patients With Major Depression and in Brains of Suicide Victims Arch Gen Psychiatry, September 1, 1996; 53(9): 803 - 810. [Abstract] [PDF]

				H.C. Middleton, J.T. Coull, B.J. Sahakian, and T.W. Robbins Clonidine-induced changes in the spectral distribution of heart rate variability correlate with performance on a test of sustained attention J Psychopharmacol, January 1, 1994; 8(1): 1 - 7. [Abstract] [PDF]

				F. Grossman, H. K. Manji, and W. Z. Potter Platelet {alpha}2-adrenoreceptors in depression: a critical examination J Psychopharmacol, January 1, 1993; 7(1_suppl): 4 - 18. [Abstract] [PDF]